|
US1019519A
(en)
|
1911-07-11 |
1912-03-05 |
Oscar Martin Polin |
Apparatus for making backing for teeth.
|
|
US4172896A
(en)
|
1978-06-05 |
1979-10-30 |
Dainippon Pharmaceutical Co., Ltd. |
Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
|
|
GB9217295D0
(en)
|
1992-08-14 |
1992-09-30 |
Wellcome Found |
Controlled released tablets
|
|
GB9315856D0
(en)
|
1993-07-30 |
1993-09-15 |
Wellcome Found |
Stabilized pharmaceutical
|
|
US5358970A
(en)
|
1993-08-12 |
1994-10-25 |
Burroughs Wellcome Co. |
Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
|
|
US5541231A
(en)
|
1993-07-30 |
1996-07-30 |
Glaxo Wellcome Inc. |
Stabilized Pharmaceutical
|
|
DE69818675T2
(de)
|
1997-07-29 |
2004-07-29 |
Alcon Laboratories, Inc., Fort Worth |
Galaktomannanpolymere und borat enthaltende augenarzneimittel
|
|
AU2483599A
(en)
|
1998-01-29 |
1999-08-16 |
Sepracor, Inc. |
Pharmaceutical uses of optically pure (-)-bupropion
|
|
US8889112B2
(en)
|
1999-09-16 |
2014-11-18 |
Ocularis Pharma, Llc |
Ophthalmic formulations including selective alpha 1 antagonists
|
|
US6451828B1
(en)
|
2000-08-10 |
2002-09-17 |
Elan Pharmaceuticals, Inc. |
Selective inhibition of glutaminase by bis-thiadiazoles
|
|
AU2002305926A1
(en)
|
2001-02-05 |
2002-10-08 |
Exegenics Inc. |
Cysteine protease inhibitors
|
|
WO2004094409A1
(en)
*
|
2003-03-27 |
2004-11-04 |
Lankenau Institute For Medical Research |
Novel ido inhibitors and methods of use
|
|
US6933289B2
(en)
|
2003-07-01 |
2005-08-23 |
Allergan, Inc. |
Inhibition of irritating side effects associated with use of a topical ophthalmic medication
|
|
EP1654002B2
(en)
|
2003-08-07 |
2014-01-29 |
Allergan, Inc. |
Compositions for delivery of therapeutics into the eyes
|
|
US20050059744A1
(en)
|
2003-09-12 |
2005-03-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
|
|
WO2005113798A2
(en)
|
2004-04-15 |
2005-12-01 |
University Of Florida Research Foundation, Inc. |
Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
|
|
US7928140B2
(en)
|
2007-08-02 |
2011-04-19 |
Amgen Inc. |
Benzothiazole PI3 kinase modulators for cancer treatment
|
|
WO2009073620A2
(en)
*
|
2007-11-30 |
2009-06-11 |
Newlink Genetics |
Ido inhibitors
|
|
TWI478709B
(zh)
|
2008-02-19 |
2015-04-01 |
Earnest Medicine Co Ltd |
A useful oral or enteral composition for the recovery of bodily functions
|
|
WO2010085797A2
(en)
*
|
2009-01-26 |
2010-07-29 |
The Trustees Of University Of Pennsylvania |
Arginase inhibitors and methods of use
|
|
US20130109643A1
(en)
|
2010-05-10 |
2013-05-02 |
The Johns Hopkins University |
Metabolic inhibitor against tumors having an idh mutation
|
|
US10064885B2
(en)
|
2010-07-09 |
2018-09-04 |
Massachusetts Institute Of Technology |
Metabolic gene, enzyme, and flux targets for cancer therapy
|
|
WO2012068512A1
(en)
|
2010-11-18 |
2012-05-24 |
Deuteria Pharmaceuticals Llc |
3-deutero-pomalidomide
|
|
RU2019121905A
(ru)
*
|
2010-12-31 |
2019-09-03 |
Астразенека Юкей Лимитед |
Ингибиторы аргиназы и способы их применения
|
|
CA2742342A1
(en)
|
2011-02-12 |
2012-08-12 |
Baylor Research Institute |
Msh3 expression status determines the responsiveness of cancer cells to the chemotherapeutic treatment with parp inhibitors and platinum drugs
|
|
FI20115876A0
(fi)
|
2011-09-06 |
2011-09-06 |
Turun Yliopisto |
Yhdistelmähoito
|
|
CN103030597B
(zh)
|
2011-09-30 |
2014-10-01 |
南昌滨西科技有限公司 |
肾脏型谷氨酰胺酶抑制剂及其制备方法和用途
|
|
CA2852685C
(en)
*
|
2011-10-19 |
2019-02-26 |
Mars, Incorporated |
Inhibitors of arginase and their therapeutic application
|
|
CN108785305B
(zh)
*
|
2011-11-21 |
2021-10-29 |
卡利泰拉生物科技公司 |
谷氨酰胺酶的杂环抑制剂
|
|
US8604016B2
(en)
|
2011-11-21 |
2013-12-10 |
Calithera Biosciences Inc. |
Heterocyclic inhibitors of glutaminase
|
|
AU2013266243A1
(en)
|
2012-05-24 |
2014-12-18 |
Beth Israel Deaconess Medical Center, Inc. |
Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
|
|
CN104797256A
(zh)
|
2012-09-10 |
2015-07-22 |
细胞基因公司 |
用于治疗局部晚期乳腺癌的方法
|
|
EP2895623B1
(en)
|
2012-09-17 |
2018-08-22 |
Agios Pharmaceuticals, Inc. |
Use of e-cadherin and vimentin for selection of treatment responsive patients
|
|
HUE056078T2
(hu)
|
2012-11-16 |
2022-01-28 |
Calithera Biosciences Inc |
Heterociklusos glutamináz inhibitorok
|
|
SG11201504022RA
(en)
|
2012-11-21 |
2015-06-29 |
Agios Pharmaceuticals Inc |
Glutamase inhibitors and method of use
|
|
WO2014079011A1
(en)
|
2012-11-22 |
2014-05-30 |
Agios Pharmaceuticals, Inc. |
Heterocyclic compounds for inhibiting glutaminase and their methods of use
|
|
HK1220640A1
(zh)
*
|
2012-12-03 |
2017-05-12 |
Calithera Biosciences, Inc. |
用谷氨醯胺酶的杂环抑制剂治疗癌症
|
|
BR112015022462A8
(pt)
*
|
2013-03-15 |
2019-11-26 |
Bristol Myers Squibb Co |
inibidores de ido, composição farmacêutica, método de inibição de atividade de indolamina 2,3-dioxigenase e uso dos referidos inibidores
|
|
WO2015061752A1
(en)
|
2013-10-25 |
2015-04-30 |
Pharmacyclics, Inc. |
Treatment using bruton's tyrosine kinase inhibitors and immunotherapy
|
|
WO2015061432A1
(en)
|
2013-10-25 |
2015-04-30 |
Calithera Biosciences, Inc. |
Treatment of viral infections with inhibitors of glutaminase
|
|
GB201322725D0
(en)
*
|
2013-12-20 |
2014-02-05 |
Immodulon Therapeutics Ltd |
Cancer therapy
|
|
US20170165364A1
(en)
*
|
2014-02-21 |
2017-06-15 |
Idac Theranostics, Inc. |
Therapeutic agent for solid cancer
|
|
WO2015138902A1
(en)
*
|
2014-03-14 |
2015-09-17 |
Calithera Biosciences, Inc. |
Combination therapy with glutaminase inhibitors
|
|
US10221459B2
(en)
|
2014-05-13 |
2019-03-05 |
Case Western Reserve University |
Compositions and methods of treating cancer harboring PIKC3A mutations
|
|
SG11201610333VA
(en)
|
2014-06-13 |
2017-01-27 |
Calithera Biosciences Inc |
Combination therapy with glutaminase inhibitors
|
|
WO2016004413A2
(en)
|
2014-07-03 |
2016-01-07 |
Board Of Regents, University Of Texas System |
Gls1 inhibitors for treating disease
|
|
WO2016004418A1
(en)
|
2014-07-03 |
2016-01-07 |
Board Of Regents, University Of Texas System |
Glutaminase inhibitor therapy
|
|
WO2016014890A1
(en)
|
2014-07-24 |
2016-01-28 |
Calithera Biosciences, Inc. |
Treatment of multiple myeloma with heterocyclic inhibitors of glutaminase
|
|
JP6889101B2
(ja)
|
2014-08-07 |
2021-06-18 |
キャリセラ バイオサイエンシーズ， インコーポレイテッド |
グルタミナーゼ阻害剤の結晶形態
|
|
WO2016054388A1
(en)
|
2014-10-03 |
2016-04-07 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Glutaminase inhibitors
|
|
US10517844B2
(en)
|
2014-11-13 |
2019-12-31 |
Buck Institute For Research On Aging |
Inhibition of proline catabolism for the treatment of cancer and other therapeutic applications
|
|
JP6768693B2
(ja)
|
2015-03-30 |
2020-10-14 |
キャリセラ バイオサイエンシーズ， インコーポレイテッド |
グルタミナーゼ阻害剤を投与する方法
|
|
BR112017021312A2
(pt)
|
2015-04-06 |
2018-06-26 |
Calithera Biosciences Inc |
tratamento de câncer de pulmão com inibidores de glutaminase
|
|
WO2017023793A2
(en)
|
2015-07-31 |
2017-02-09 |
The Johns Hopkins University |
Methods for cancer and immunotherapy using glutamine analogues, including don
|
|
ES2900482T3
(es)
|
2015-10-01 |
2022-03-17 |
Gilead Sciences Inc |
Combinación de un inhibidor de Btk y un inhibidor de punto de control para el tratamiento del cáncer
|
|
SG11201802830QA
(en)
|
2015-10-05 |
2018-05-30 |
Calithera Biosciences Inc |
Combination therapy with glutaminase inhibitors and immuno-oncology agents
|
|
HRP20220237T1
(hr)
|
2016-05-20 |
2022-04-29 |
Biohaven Therapeutics Ltd. |
Primjena riluzola, prolijekova riluzola ili analoga riluzola sa imunoterapijama za liječenje raka
|
|
WO2018039441A1
(en)
|
2016-08-25 |
2018-03-01 |
Calithera Biosciences, Inc. |
Combination therapy with glutaminase inhibitors
|
|
WO2018039544A1
(en)
|
2016-08-25 |
2018-03-01 |
Calithera Biosciences, Inc. |
Combination therapy with glutaminase inhibitors
|
|
US20180055825A1
(en)
|
2016-08-25 |
2018-03-01 |
Yu Liang |
Treatment of cancer with inhibitors of glutaminase
|
|
AU2018231058A1
(en)
|
2017-03-10 |
2019-09-19 |
Calithera Biosciences, Inc. |
Combination therapy with glutaminase inhibitors
|
|
US20210177841A1
(en)
*
|
2017-11-03 |
2021-06-17 |
Calithera Biosciences, Inc. |
Conjoint therapy with glutaminase inhibitors
|